Transforming Pharmaceutical Manufacturing in the 21st Century – Indiana as a Center for Biopharmaceutical Manufacturing
Dr. Svensson’s research has centered on the mechanism of idiosyncratic drug reactions. His laboratory has focused on the genetic, environmental, and immunological factors that predispose patients to adverse drug reactions that affect the skin and liver. His laboratory was the first to demonstrate the ability of human skin cells to metabolize drugs, resulting in protein haptenation and activation of stress signals.
Dr. Svensson has served as a member or chair of numerous grant review panels for the National Institutes of Health. He is a regular reviewer for numerous scientific journals, including the Journal of Pharmacology & Experimental Therapeutics and JAMA - the Journal of the American Medical Association. He is currently the Associate Editor for the AAPS Journal and is a Fellow of the American Association of Pharmaceutical Scientists.
Researchers should cite this work as follows:
(2008), "Transforming Pharmaceutical Manufacturing in the 21st Century – Indiana as a Center for Biopharmaceutical Manufacturing," http://nanohub.org/resources/5062.
Centre for Cellular and Molecular Biology, Hyderabad, India